Published in J Pharmacol Exp Ther on December 01, 1983
Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx (2004) 1.71
From bench to drug: human seizure modeling using Drosophila. Prog Neurobiol (2007) 1.24
Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited. Ther Adv Neurol Disord (2008) 1.12
Protein kinase C-dependent modulation of Na+ currents increases the excitability of rat neocortical pyramidal neurones. J Physiol (2000) 1.03
Site of anticonvulsant action on sodium channels: autoradiographic and electrophysiological studies in rat brain. Proc Natl Acad Sci U S A (1987) 0.94
Mood stabilizer psychopharmacology. Clin Neurosci Res (2002) 0.93
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons. Br J Pharmacol (1999) 0.90
Sodium channels from human brain RNA expressed in Xenopus oocytes. Basic electrophysiologic characteristics and their modification by diphenylhydantoin. J Clin Invest (1989) 0.82
Diphenytoin, riluzole and lidocaine: three sodium channel blockers, with different mechanisms of action, decrease hippocampal epileptiform activity. Neuropharmacology (2013) 0.78
Microionophoretic study with milacemide, a glycine precursor, on mammalian central nervous system cells. Br J Pharmacol (1990) 0.77
Electrophysiological actions of phenytoin on N-methyl-D-aspartate receptor-mediated responses in rat hippocampus in vitro. Br J Pharmacol (1995) 0.75
Effect of phenytoin on sodium conductances in rat hippocampal CA1 pyramidal neurons. J Neurophysiol (2016) 0.75
It's time to revise the definition of status epilepticus. Epilepsia (1999) 3.15
Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci (1997) 2.51
Antigen-driven B cell differentiation in vivo. J Exp Med (1993) 2.35
Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms. Mol Pharmacol (1996) 2.14
Assembly of GABAA receptor subunits: alpha 1 beta 1 and alpha 1 beta 1 gamma 2S subunits produce unique ion channels with dissimilar single-channel properties. J Neurosci (1993) 2.12
GABAA receptor subunit gamma2 and delta subtypes confer unique kinetic properties on recombinant GABAA receptor currents in mouse fibroblasts. J Physiol (1999) 2.02
Assembly of GABAA receptor subunits: role of the delta subunit. J Neurosci (1994) 1.94
HBTU activation for automated Fmoc solid-phase peptide synthesis. Pept Res (1992) 1.91
Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery (1997) 1.90
Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol (1977) 1.72
Intraoperative angiography in cerebral aneurysm surgery: a prospective study of 100 craniotomies. Neurosurgery (1996) 1.69
Combined laminectomy and thoracoscopic resection of a dumbbell neurofibroma: technical case report. Neurosurgery (1999) 1.56
Intraburst kinetic properties of the GABAA receptor main conductance state of mouse spinal cord neurones in culture. J Physiol (1990) 1.56
The segment inversion site of herpes simplex virus type 1 adopts a novel DNA structure. J Biol Chem (1987) 1.54
Neurosteroid regulation of GABAA receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J Physiol (1992) 1.53
Benzodiazepine and beta-carboline regulation of single GABAA receptor channels of mouse spinal neurones in culture. J Physiol (1994) 1.50
Kinetic properties of the glycine receptor main- and sub-conductance states of mouse spinal cord neurones in culture. J Physiol (1991) 1.50
Proteome composition and codon usage in spirochaetes: species-specific and DNA strand-specific mutational biases. Nucleic Acids Res (1999) 1.47
Single channel properties of recombinant GABAA receptors containing gamma 2 or delta subtypes expressed with alpha 1 and beta 3 subtypes in mouse L929 cells. J Physiol (1997) 1.46
Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture. Proc Natl Acad Sci U S A (1987) 1.44
A novel GABRG2 mutation associated with febrile seizures. Neurology (2006) 1.41
Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. Ann Neurol (1990) 1.40
Emergency lumbar puncture in adults. Can Fam Physician (1989) 1.38
Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital. Ann Neurol (1989) 1.38
Embryological basis of some aspects of cerebral vascular fistulas and malformations. J Neurosurg (1996) 1.37
Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism. Mol Psychiatry (2009) 1.36
Alpha1 and alpha6 subunits specify distinct desensitization, deactivation and neurosteroid modulation of GABA(A) receptors containing the delta subunit. Neuropharmacology (2002) 1.34
Consecutive A X T pairs can adopt a left-handed DNA structure. Proc Natl Acad Sci U S A (1986) 1.33
Two configurations of static magnetic fields for treating rheumatoid arthritis of the knee: a double-blind clinical trial. Arch Phys Med Rehabil (2001) 1.30
Barbiturate enhancement of GABA-mediated inhibition and activation of chloride ion conductance: correlation with anticonvulsant and anesthetic actions. Brain Res (1981) 1.26
Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol (1995) 1.26
Specific-opiate-induced depression of transmitter release from dorsal root ganglion cells in culture. Science (1978) 1.23
Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurones. J Physiol (1986) 1.22
Calcium- and sodium-dependent action potentials of mouse spinal cord and dorsal root ganglion neurons in cell culture. J Neurophysiol (1982) 1.21
Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones. Nature (1977) 1.20
Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype. Mol Pharmacol (1996) 1.20
Structural determinants of fast desensitization and desensitization-deactivation coupling in GABAa receptors. J Neurosci (2001) 1.19
Diethyl pyrocarbonate can detect a modified DNA structure induced by the binding of quinoxaline antibiotics. Nucleic Acids Res (1988) 1.18
Agonist Trapping by GABAA Receptor Channels. J Neurosci (2001) 1.18
Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther (1986) 1.17
Pentobarbital and picrotoxin have reciprocal actions on single GABAA receptor channels. Neurosci Lett (1989) 1.16
A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors. Neurology (2003) 1.15
The polyamine spermine has multiple actions on N-methyl-D-aspartate receptor single-channel currents in cultured cortical neurons. Mol Pharmacol (1992) 1.13
Cyclic AMP-dependent protein kinase decreases GABAA receptor current in mouse spinal neurons. Neuron (1990) 1.13
Opioid peptides decrease calcium-dependent action potential duration of mouse dorsal root ganglion neurons in cell culture. Brain Res (1982) 1.12
Opioid peptides with differential affinity for mu and delta receptors decrease sensory neuron calcium-dependent action potentials. J Pharmacol Exp Ther (1983) 1.12
Assembly of GABAA receptor subunits: analysis of transient single-cell expression utilizing a fluorescent substrate/marker gene technique. J Neurosci (1993) 1.11
Different actions of anticonvulsant and anesthetic barbiturates revealed by use of cultured mammalian neurons. Science (1978) 1.10
Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons. J Neurosci (1994) 1.09
The role of an alpha subtype M2-M3 His in regulating inhibition of GABAA receptor current by zinc and other divalent cations. J Neurosci (1998) 1.09
Cyclic AMP-dependent protein kinase enhances hippocampal dentate granule cell GABAA receptor currents. J Neurophysiol (1996) 1.09
Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action. Epilepsia (1994) 1.06
2-Chloroadenosine reduces the N calcium current of cultured mouse sensory neurones in a pertussis toxin-sensitive manner. J Physiol (1989) 1.06
Activators of adenylate cyclase and cyclic AMP prolong calcium-dependent action potentials of mouse sensory neurons in culture by reducing a voltage-dependent potassium conductance. J Neurosci (1987) 1.06
Cloned GABA receptors are maintained in a stable cell line: allosteric and channel properties. Eur J Pharmacol (1990) 1.05
Learning deficits after experimental subarachnoid hemorrhage in rats. Neuroscience (2010) 1.05
mu-Opioid receptor-mediated reduction of neuronal calcium current occurs via a G(o)-type GTP-binding protein. J Neurosci (1994) 1.04
Isolated, primary extranodal Hodgkin's disease of the spine: case report. Neurosurgery (2001) 1.03
Membrane depolarization and prolongation of calcium-dependent action potentials of mouse neurons in cell culture by two convulsants: bicuculline and penicillin. Brain Res (1982) 1.03
Spontaneous and gamma-aminobutyric acid (GABA)-activated GABA(A) receptor channels formed by epsilon subunit-containing isoforms. Mol Pharmacol (1999) 1.03
Regional myocardial perfusion after experimental subarachnoid hemorrhage. Stroke (2000) 1.03
GABA and bicuculline actions on mouse spinal cord and cortical neurons in cell culture. Brain Res (1982) 1.01
Heterogeneous sensitivity of cultured dorsal root ganglion neurones to opioid peptides selective for mu- and delta-opiate receptors. Nature (1982) 1.01
Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine. J Med Chem (1986) 1.01
Substance P: ionic basis for depolarizing responses of mouse spinal cord neurons in cell culture. J Neurosci (1982) 1.00
Posterior decompression of the vertebral artery narrowed by cervical osteophyte: case report. Surg Neurol (1999) 1.00
Barbiturate reduction of calcium-dependent action potentials: correlation with anesthetic action. Brain Res (1982) 1.00
Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev (1991) 1.00
Mutation of the 9' leucine in the GABA(A) receptor gamma2L subunit produces an apparent decrease in desensitization by stabilizing open states without altering desensitized states. Neuropharmacology (2001) 1.00
Polyamine regulation of N-methyl-D-aspartate receptor channels. Annu Rev Pharmacol Toxicol (1995) 1.00
Whole-cell and single-channel alpha1 beta1 gamma2S GABAA receptor currents elicited by a "multipuffer" drug application device. Pflugers Arch (1996) 0.99
Barbiturates decrease voltage-dependent calcium conductance of mouse neurons in dissociated cell culture. Mol Pharmacol (1985) 0.99
Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration. J Pharmacol Exp Ther (1985) 0.97
Forskolin and phorbol esters reduce the same potassium conductance of mouse neurons in culture. Science (1987) 0.97
Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Res (1993) 0.97
Anticonvulsant drugs: mechanisms of action. Adv Neurol (1986) 0.97
Postnatal development of hippocampal dentate granule cell gamma-aminobutyric acidA receptor pharmacological properties. Mol Pharmacol (1999) 0.96
Valproic acid augments GABA-mediated postsynaptic inhibition in cultured mammalian neurons. Brain Res (1979) 0.96
Aplastic anemia in a patient receiving felbamate for complex partial seizures. Neurology (1995) 0.96
Mechanism for the postive inotropic effect of angiotensin II on isolated cardiac muscle. Circ Res (1976) 0.95
Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci Lett (1990) 0.95
Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits. Mol Pharmacol (1996) 0.94
Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther (1986) 0.94
The 2-amino group of guanine is absolutely required for specific binding of the anti-cancer antibiotic echinomycin to DNA. Nucleic Acids Res (1992) 0.94
Functional properties of recombinant GABA(A) receptors composed of single or multiple beta subunit subtypes. Neuropharmacology (1998) 0.93
Incorporation of the pi subunit into functional gamma-aminobutyric Acid(A) receptors. Mol Pharmacol (1999) 0.93
Surgical manipulation of primate cerebral arteries in established vasospasm. J Neurosurg (1991) 0.93
Mechanisms of microthrombi formation after experimental subarachnoid hemorrhage. Neuroscience (2012) 0.93
Derivation of general equations describing tracer diffusion in any two-compartment tissue with application to ionic diffusion in cylindrical muscle bundles. J Theor Biol (1974) 0.93
The cyclic AMP-dependent protein kinase catalytic subunit selectively enhances calcium currents in rat nodose neurones. J Physiol (1990) 0.93
Etiology of cerebral vasospasm. Acta Neurochir Suppl (1999) 0.93
Neuropeptide Y reduces calcium current and inhibits acetylcholine release in nodose neurons via a pertussis toxin-sensitive mechanism. J Neurophysiol (1990) 0.93
Opiate peptide modulation of amino acid responses suggests novel form of neuronal communication. Science (1978) 0.92
Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group. Seizure (2000) 0.92
Protein kinase C enhances recombinant bovine alpha 1 beta 1 gamma 2L GABAA receptor whole-cell currents expressed in L929 fibroblasts. Neuron (1994) 0.92
The role of alpha1 and alpha6 subtype amino-terminal domains in allosteric regulation of gamma-aminobutyric acida receptors. Mol Pharmacol (1997) 0.92
Dynorphin reduces calcium-dependent action potential duration by decreasing voltage-dependent calcium conductance. Neurosci Lett (1984) 0.92